oa Editorial Review of 2012

Since the conception of the journal Current Radiopharmaceuticals in January 2008, we have been inundated with a variety of research articles ranging from discussions of the use of radiopharmaceuticals in imaging to drug discovery and targeted alpha therapy. All these articles have been peer reviewed by members of editorial board including guest editors. Here, I would personally like to take this opportunity to thank everyone on the editorial board who has volunteered their time to review the many articles that we have received and also the editorial staff at Bentham Science. Current Radiopharmaceuticals has captured the imagination of many scientists working in Nuclear Medicine. The journal owes its success to all the authors who have submitted high quality manuscripts sharing in-depth knowledge in the area of radiopharmaceuticals to produce thematic issues. The idea behind thematic ‘Hot Topic’ issues is to generate maximum impact to the published matter in that particular area of radiopharmaceuticals and Nuclear Medicine to drive the journals' impact factor. The fourth volume of Current Radiopharmaceuticals contained articles and thematic issues on a range of hot topics. The efforts and determination of the editorial board and guest editors have helped to promote the journal to MEDLINE since July 2011. MEDLINE is the primary component of PubMed®, part of the Entrez series of databases provided by NLM's National Center for Biotechnology Information (NCBI). Publications covered in MEDLINE are mostly scholarly journals, newspapers, magazines, and newsletters considered useful in the field of life sciences. In this review I have summarized all the abstracts from 2011 issues 1 to 4. The first article of the year by Nalla et al. was entitled ‘Easy and Efficient 111Indium Labeling of Long-Term Stored DTPA Conjugated Protein’, and gave an outline on the labelling efficiency of long-term stored DTPA-conjugates in the development of radiopharmaceuticals and contrast agents.......